PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT02883114
- Locations
- 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
- First Posted Date
- 2016-08-26
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 82
- Registration Number
- NCT02880371
- Locations
- 🇺🇸
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
🇺🇸UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States
🇺🇸UCLA Hematology/Oncology, Los Angeles, California, United States
Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2018-05-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 96
- Registration Number
- NCT02871037
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Dental Pain Study Comparing The Analgesic Efficacy Of Ibuprofen/Caffeine
- First Posted Date
- 2016-08-11
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 374
- Registration Number
- NCT02863575
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
A Multiple Dose Safety And Pharmacokinetic (PK) Study Of PF-06427878 In Overweight-Obese, Otherwise Healthy Subjects
- First Posted Date
- 2016-08-04
- Last Posted Date
- 2017-05-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT02855177
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Glendale, California, United States
🇺🇸Qps-Mra, Llc, South Miami, Florida, United States
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 147
- Registration Number
- NCT02850406
- Locations
- 🇺🇸
Our Lady of the Lake Children's Hospital (IP Address), Baton Rouge, Louisiana, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 57
- Registration Number
- NCT02847650
- Locations
- 🇺🇸
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
🇺🇸Asheville Neurology Specialists PA, Asheville, North Carolina, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 16
- Registration Number
- NCT02838264
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain
- Conditions
- Pain
- Interventions
- Drug: FDC IBU/APAP 250 mg/500 mgDrug: Placebo
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 123
- Registration Number
- NCT02837952
- Locations
- 🇺🇸
Pharmaceutical Research Associates, Inc., Salt Lake City, Utah, United States
A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
- First Posted Date
- 2016-07-18
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Pfizer
- Registration Number
- NCT02836028